Fucoidan from brown algae inhibited the expression of cathepsin D and Bax in the murine dopaminergic nerve precursor cell line, MN9D (neuroblastoma), and indicated its prospective role as a neuroprotective agent in Parkinson’s disease treatment [126]. This evidence concerns the gene CTSD and neuroblastoma.